Matushansky Igor's Form 4 filing
HOOKIPA Pharma Inc. (HOOK) · filed Jan 12, 2022
- Accession no.
- 0001104659-22-003430
- Filed
- Jan 12, 2022, 10:07 AM ET
- Trade date
- Dec 21, 2021
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $37.2K. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Matushansky IgorCIK 0001768208 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 | Common Stock | MOption exerciseAcquired | +8,079 | $0.10 | +$807.9 | 85,482 | Direct | |
| Dec 21, 2021 | Common Stock | SSaleDisposed | −5,304 | $2.49 | −$13,206.96 | 80,178 | Direct | |
| Dec 21, 2021 | Common Stock | MOption exerciseAcquired | +11,366 | $0.10 | +$1,136.6 | 91,544 | Direct | |
| Dec 21, 2021 | Common Stock | SSaleDisposed | −7,440 | $2.49 | −$18,525.6 | 84,104 | Direct | |
| Dec 21, 2021 | Common Stock | MOption exerciseAcquired | +3,408 | $0.10 | +$340.8 | 87,512 | Direct | |
| Dec 21, 2021 | Common Stock | SSaleDisposed | −2,205 | $2.49 | −$5,490.45 | 85,307 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 | Common Stock | MOption exerciseDisposed | −8,079 | $0.00 | $0 | 0 | Direct | |
| Dec 21, 2021 | Common Stock | MOption exerciseDisposed | −11,366 | $0.00 | $0 | 2,842 | Direct | |
| Dec 21, 2021 | Common Stock | MOption exerciseDisposed | −3,408 | $0.00 | $0 | 4,261 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.